Heart Under Siege? Breakthroughs in HEFH Management Market Set to Save Millions from Silent Killer!
In a world where cholesterol is a silent assassin, Heterozygous Familial Hypercholesterolemia (HeFH) stands out as a genetic ticking time bomb. Affecting millions globally, this inherited condition leads to dangerously high cholesterol levels and, if untreated, a dramatically increased risk of early cardiovascular disease. But here’s the game-changer—the Heterozygous...
0 Kommentare
0 Anteile